Literature DB >> 19153310

Airway management in children with mucopolysaccharidoses.

Andrea H Yeung1, Morton J Cowan, Biljana Horn, Kristina W Rosbe.   

Abstract

OBJECTIVE: To review of the natural history of airway disease in children with muccopolysaccharidoses (MPSs), which represent a group of hereditary progressive disorders caused by excessive accumulation of glycosaminoglycans in various tissues.
DESIGN: Retrospective medical chart review.
SETTING: Tertiary referral academic medical center. PATIENTS: Twenty-seven children with MPSs. MAIN OUTCOME MEASURES: A review of the medical charts of 27 children with MPSs between February 1, 1984, and February 1, 2004, was performed to examine the natural history of airway disease.
RESULTS: Clinically upper airway obstruction was noted in 19 patients (70%) and necessitated a tracheotomy in 3 patients (11%). Fourteen of the 27 patients underwent bone marrow transplantation, and successful engraftment resulted in a significant decrease in obstructive symptoms in 13 of the 14 patients.
CONCLUSIONS: Patients affected by MPSs require the vigilant attention of the otolaryngologist, as sleep apnea and upper airway obstruction are common complications. Successful bone marrow engraftment may alter the natural history of airway disease and result in substantial improvement in symptomatic airway disease in children with MPSs.

Entities:  

Mesh:

Year:  2009        PMID: 19153310     DOI: 10.1001/archoto.2008.515

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  16 in total

1.  Correlation Between Flexible Fiberoptic Laryngoscopic and Polysomnographic Findings in Patients with Mucopolysaccharidosis Type VI.

Authors:  Denise Rotta Ruttkay Pereira; Claudia Schweiger; Carolina F de Souza; Simone Fagondes; Denise Manica; Roberto Giugliani; Gabriel Kuhl; Paulo J C Marostica
Journal:  JIMD Rep       Date:  2015-11-29

2.  Home sleep study characteristics in patients with mucopolysaccharidosis.

Authors:  Çiğdem Seher Kasapkara; Leyla Tümer; Ayşe Tana Aslan; Alev Hasanoğlu; Fatih Süheyl Ezgü; Aynur Küçükçongar; Zeynep Tunca; Oğuz Köktürk
Journal:  Sleep Breath       Date:  2013-05-22       Impact factor: 2.816

3.  Prevalence of obstructive sleep apnea in patients with mucopolysaccharidosis types I, II, and VI in a reference center.

Authors:  Gustavo A Moreira; Sandra O Kyosen; Camilla L Patti; Ana Maria Martins; Sergio Tufik
Journal:  Sleep Breath       Date:  2014-04-05       Impact factor: 2.816

Review 4.  Clinical overview and treatment options for non-skeletal manifestations of mucopolysaccharidosis type IVA.

Authors:  Christian J Hendriksz; Maisoon Al-Jawad; Kenneth I Berger; Sara M Hawley; Rebecca Lawrence; Ciarán Mc Ardle; C Gail Summers; Elizabeth Wright; Elizabeth Braunlin
Journal:  J Inherit Metab Dis       Date:  2012-02-23       Impact factor: 4.982

5.  Mechanotransduction: tuning stem cells fate.

Authors:  Francesco D'Angelo; Roberto Tiribuzi; Ilaria Armentano; Josè Maria Kenny; Sabata Martino; Aldo Orlacchio
Journal:  J Funct Biomater       Date:  2011-06-21

6.  Mucopolysaccharidosis I; Parental beliefs about the impact of disease on the quality of life of their children.

Authors:  A Soni-Jaiswal; J Mercer; S A Jones; I A Bruce; P Callery
Journal:  Orphanet J Rare Dis       Date:  2016-07-12       Impact factor: 4.123

7.  Voice alterations in patients with Morquio A syndrome.

Authors:  Krzysztof Szklanny; Ryszard Gubrynowicz; Anna Tylki-Szymańska
Journal:  J Appl Genet       Date:  2017-12-23       Impact factor: 3.240

Review 8.  ENT and mucopolysaccharidoses.

Authors:  Pier Marco Bianchi; Renato Gaini; Silvano Vitale
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

Review 9.  Respiratory and sleep disorders in mucopolysaccharidosis.

Authors:  Kenneth I Berger; Simone C Fagondes; Roberto Giugliani; Karen A Hardy; Kuo Sheng Lee; Ciarán McArdle; Maurizio Scarpa; Martin J Tobin; Susan A Ward; David M Rapoport
Journal:  J Inherit Metab Dis       Date:  2012-11-15       Impact factor: 4.982

10.  Management of otolaryngological manifestations in mucopolysaccharidoses: our experience.

Authors:  M Mesolella; M Cimmino; E Cantone; A Marino; M Cozzolino; R Della Casa; G Parenti; M Iengo
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-08       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.